Severe asthma and fungi: current evidence

被引:106
作者
Agarwal, Ritesh [1 ]
Gupta, Dheeraj [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India
关键词
severe asthma with fungal sensitization; asthma; Aspergillus; allergic bronchopulmonary aspergillosis; ABPA; azoles; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; CYSTIC-FIBROSIS PATIENTS; INTENSIVE-CARE-UNIT; SERUM IGE LEVELS; RECOMBINANT ALLERGENS; FUMIGATUS ALLERGENS; CLINICAL-SIGNIFICANCE; CHILDHOOD ASTHMA; SPORE COUNTS; NORTH-INDIA;
D O I
10.3109/13693786.2010.504752
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Bronchial asthma is an inflammatory disease of the airways which may be worsened due to numerous extrinsic factors. The most common trigger is continuous exposure to allergens of which fungal agents are important factors. There is overwhelming evidence for the presence of fungal sensitization in patients with asthma. The diagnosis of fungal sensitization can be made either with skin testing with antigens derived from fungi or measuring specific IgE levels. There is also a strong association between fungal sensitization and severity of asthma. Whether this relationship is causal or just casual remains to be investigated. A variety of fungi are known to cause sensitization in asthmatics, but the most important fungal agent(s) causing severe asthma with fungal sensitization (SAFS) are currently unknown. Aspergillus species seem to be the strongest candidates as only with Aspergillus spp. does one encounter two extreme immunologic phenomena, i.e., the Aspergillus-sensitive asthma and allergic bronchopulmonary aspergillosis. The initial clinical management of SAFS should be the same as asthmatics without fungal sensitization. There is some evidence of the role of itraconazole in the management of SAFS but its routine use in SAFS requires further evaluation. This review summarizes the current evidence on the link between fungi and severe asthma.
引用
收藏
页码:S150 / S157
页数:8
相关论文
共 88 条
  • [1] EFFECTS OF BIFONAZOLE, FLUCONAZOLE, ITRACONAZOLE, AND TERBINAFINE ON THE CHEMILUMINESCENCE RESPONSE OF IMMUNE CELLS
    ABRUZZO, GK
    FROMTLING, RA
    TURNBULL, TA
    GILTINAN, DM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 (01) : 61 - 68
  • [2] Agarwal R, 2009, Monaldi Arch Chest Dis, V71, P161
  • [3] Agarwal R, 2009, INT J TUBERC LUNG D, V13, P936
  • [4] AGARWAL R, 2010, INT J RESP IN PRESS
  • [5] AGARWAL R, 2010, MED MYCOL IN PRESS
  • [6] Allergic bronchopulmonary aspergillosis - Lessons from 126 patients attending a chest clinic in north India
    Agarwal, Ritesh
    Gupta, Dheeraj
    Aggarwal, Ashutosh N.
    Behera, Digamber
    Jindal, Surinder K.
    [J]. CHEST, 2006, 130 (02) : 442 - 448
  • [7] Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis - An analysis of 155 patients
    Agarwal, Ritesh
    Gupta, Dheeraj
    Aggarwal, Ashutosh N.
    Saxena, Akshay K.
    Chakrabarti, Arunaloke
    Jindal, Surinder K.
    [J]. CHEST, 2007, 132 (04) : 1183 - 1190
  • [8] Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India
    Agarwal, Ritesh
    Nath, Alok
    Aggarwal, Ashutosh N.
    Gupta, Dheeraj
    Chakrabarti, Arunaloke
    [J]. MYCOSES, 2010, 53 (02) : 138 - 143
  • [9] Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis
    Agarwal, Ritesh
    Gupta, Dheeraj
    Aggarwal, Ashutosh N.
    Saxena, Akshay K.
    Saikia, Biman
    Chakrabarti, Arunaloke
    Jindal, Surinder K.
    [J]. RESPIRATORY MEDICINE, 2010, 104 (02) : 204 - 210
  • [10] Agarwal R, 2010, ASPERGILLOSIS: FROM DIAGNOSIS TO PREVENTION, P707, DOI 10.1007/978-90-481-2408-4_42